CMS advised Bruker, while Kellerhals Carrard advised Biognosys AG. Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a...
Bruker’s Strategic Partnership with Biognosys
NLS Pharmaceutics’ $30 Million Purchase Agreement with BVF Partners L.P.
Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd. NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss...
Kontivia AG-Led Entrepreneurs Group’s Acquisition of Katadyn Group
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
MoonLake Immunotherapeutics AG’s Business Combination With Helix Acquisition Corp.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
MoonLake Immunotherapeutics AG’s Series A Financing Round
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...
Qnami’s CHF 4 Million Series A Financing Round
Kellerhals Carrard assisted Qnami on the deal. Quantum Tech startup Qnami closed its Series A Financing Round raising a total of CHF 4 million led by the...